FDA requires lower doses for sleep medications
WASHINGTON -- The Food and Drug Administration is requiring makers of Ambien and similar sleeping pills to lower the dosage of their drugs, based on studies suggesting patients face a higher risk of injury due to morning drowsiness.
The agency says new research shows that the widely-used sleeping drugs remain in the blood at levels high enough to interfere with driving, which increases the risk of car accidents.
Regulators are ordering drug manufacturers to cut the dose of the medications in half for women, who process the drug more slowly. The FDA is also recommending that manufacturers use the lower doses for men, though it will not be mandatory.
The new doses apply to all insomnia treatments containing the drug zolpidem, which is sold under the brands Ambien, Edluar and Zolpimist.
drugs, DUI, prescription drug, FDA, driving, health
- Child thrown from apartment fire in Hayward 55 min ago
- Albertsons parent Cerberus to buy Safeway
- Peninsula cold case murders linked to Reno killing
- 7 On Your Side: The dark side of green lighting
- Two injured in two-alarm fire in San Jose 3 min ago
- Senate blocks change to military sex assault cases
- Oakland mayor to deliver State of the City address
- Oakland teen accused in AC Transit fire in court
- Batkid was scheduled to appear at Oscars
- Bryan Stow attackers charged with federal crimes
- Some have privacy concerns with wearable technology
- Wheel of Fortune is coming to Northern California!
- roundup: Nob Hill gas leak; Scam warning
- weather: Bay Area weather forecast for Friday
Most Viewed StoriesMost Viewed Photos